JAK2 and myeloproliferative neoplasm: Neutrophils expressing JAK2-V617F, but not CALR mutations, drive inflammation in MPN by producing pro-inflammatory cytokines and evading clearance through upregulation of the “don’t-eat-me” signal CD24 via GM-CSF-JAK2-STAT5 signaling.